117 related articles for article (PubMed ID: 36352838)
21. Expression of miR‑26a exhibits a negative correlation with HMGA1 and regulates cancer progression by targeting HMGA1 in lung adenocarcinoma cells.
Sekimoto N; Suzuki A; Suzuki Y; Sugano S
Mol Med Rep; 2017 Feb; 15(2):534-542. PubMed ID: 28000891
[TBL] [Abstract][Full Text] [Related]
22. Clinical Implications of Extracellular HMGA1 in Breast Cancer.
Méndez O; Pérez J; Soberino J; Racca F; Cortés J; Villanueva J
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31779212
[TBL] [Abstract][Full Text] [Related]
23. HMGA1 exacerbates tumor progression by activating miR-222 through PI3K/Akt/MMP-9 signaling pathway in uveal melanoma.
Cheng Y; Cheng T; Zhao Y; Qu Y
Cell Signal; 2019 Nov; 63():109386. PubMed ID: 31394192
[TBL] [Abstract][Full Text] [Related]
24. Dynamic and differential in vivo modifications of the isoform HMGA1a and HMGA1b chromatin proteins.
Edberg DD; Adkins JN; Springer DL; Reeves R
J Biol Chem; 2005 Mar; 280(10):8961-73. PubMed ID: 15591590
[TBL] [Abstract][Full Text] [Related]
25. Immunoglobulin E induces VEGF production in mast cells and potentiates their pro-tumorigenic actions through a Fyn kinase-dependent mechanism.
Jiménez-Andrade GY; Ibarra-Sánchez A; González D; Lamas M; González-Espinosa C
J Hematol Oncol; 2013 Aug; 6():56. PubMed ID: 23915951
[TBL] [Abstract][Full Text] [Related]
26. PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways.
Wei F; Zhang T; Deng SC; Wei JC; Yang P; Wang Q; Chen ZP; Li WL; Chen HC; Hu H; Cao J
Cancer Lett; 2019 May; 450():1-13. PubMed ID: 30776481
[TBL] [Abstract][Full Text] [Related]
27. HMGA1 Promotes Hepatic Metastasis of Colorectal Cancer by Inducing Expression of Glucose Transporter 3 (GLUT3).
Yang M; Guo Y; Liu X; Liu N
Med Sci Monit; 2020 Sep; 26():e924975. PubMed ID: 32989212
[TBL] [Abstract][Full Text] [Related]
28. Expression and role of HMGA1 in renal cell carcinoma.
Takaha N; Sowa Y; Takeuchi I; Hongo F; Kawauchi A; Miki T
J Urol; 2012 Jun; 187(6):2215-22. PubMed ID: 22503056
[TBL] [Abstract][Full Text] [Related]
29. High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells.
Zhang Y; Ma T; Yang S; Xia M; Xu J; An H; Yang Y; Li S
Mol Cell Biochem; 2011 Nov; 357(1-2):363-71. PubMed ID: 21656127
[TBL] [Abstract][Full Text] [Related]
30. HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer.
Fu F; Wang T; Wu Z; Feng Y; Wang W; Zhou S; Ma X; Wang S
Cell Death Dis; 2018 May; 9(6):594. PubMed ID: 29789601
[TBL] [Abstract][Full Text] [Related]
31. Crucial role of HMGA1 in the self-renewal and drug resistance of ovarian cancer stem cells.
Kim DK; Seo EJ; Choi EJ; Lee SI; Kwon YW; Jang IH; Kim SC; Kim KH; Suh DS; Seong-Jang K; Lee SC; Kim JH
Exp Mol Med; 2016 Aug; 48(8):e255. PubMed ID: 27561949
[TBL] [Abstract][Full Text] [Related]
32. MiR-195 reverses 5-FU resistance through targeting HMGA1 in gastric cancer cells.
Wang CQ
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3771-3778. PubMed ID: 31115003
[TBL] [Abstract][Full Text] [Related]
33. Arthritis augments breast cancer metastasis: role of mast cells and SCF/c-Kit signaling.
Das Roy L; Curry JM; Sahraei M; Besmer DM; Kidiyoor A; Gruber HE; Mukherjee P
Breast Cancer Res; 2013 Apr; 15(2):R32. PubMed ID: 23577751
[TBL] [Abstract][Full Text] [Related]
34. HMGA1 promoting gastric cancer oncogenic and glycolytic phenotypes by regulating c-myc expression.
Cao XP; Cao Y; Zhao H; Yin J; Hou P
Biochem Biophys Res Commun; 2019 Aug; 516(2):457-465. PubMed ID: 31229266
[TBL] [Abstract][Full Text] [Related]
35. The a3 isoform vacuolar type H⁺-ATPase promotes distant metastasis in the mouse B16 melanoma cells.
Nishisho T; Hata K; Nakanishi M; Morita Y; Sun-Wada GH; Wada Y; Yasui N; Yoneda T
Mol Cancer Res; 2011 Jul; 9(7):845-55. PubMed ID: 21669964
[TBL] [Abstract][Full Text] [Related]
36. HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma.
Piscuoglio S; Zlobec I; Pallante P; Sepe R; Esposito F; Zimmermann A; Diamantis I; Terracciano L; Fusco A; Karamitopoulou E
Histopathology; 2012 Feb; 60(3):397-404. PubMed ID: 22276603
[TBL] [Abstract][Full Text] [Related]
37. Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer.
Maurizio E; Wiśniewski JR; Ciani Y; Amato A; Arnoldo L; Penzo C; Pegoraro S; Giancotti V; Zambelli A; Piazza S; Manfioletti G; Sgarra R
Mol Cell Proteomics; 2016 Jan; 15(1):109-23. PubMed ID: 26527623
[TBL] [Abstract][Full Text] [Related]
38. A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness.
Pegoraro S; Ros G; Ciani Y; Sgarra R; Piazza S; Manfioletti G
Oncotarget; 2015 Aug; 6(22):19087-101. PubMed ID: 26265440
[TBL] [Abstract][Full Text] [Related]
39. High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma.
Liau SS; Rocha F; Matros E; Redston M; Whang E
Cancer; 2008 Jul; 113(2):302-14. PubMed ID: 18473350
[TBL] [Abstract][Full Text] [Related]
40. HMGA1 in cancer: Cancer classification by location.
Wang Y; Hu L; Zheng Y; Guo L
J Cell Mol Med; 2019 Apr; 23(4):2293-2302. PubMed ID: 30614613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
